Page 55 - Medical Parasitology_ A Textbook ( PDFDrive )
P. 55

Types of Malarial Parasites and Their Morphology                47

              5.  Culture
                 This method is rarely used for diagnostic purposes. It is mainly used for
              research.


              Treatment


              1.  Treatment of uncomplicated malaria
                 In areas with chloroquine-susceptible infections, adults, and children are
              treated with either artemisinin-based combination therapy (ACT) (except
              women in first trimester of pregnancy) or chloroquine. In cases of chloroquine
              resistance, ACT is given. In uncomplicated P. falciparum infection, ACT is
              used for treatment (except women in first trimester of pregnancy). Infected
              pregnant women in their first trimester in areas of chloroquine resistance are
              treated with quinine. For prevention of relapse in vivax and ovale, primaquine
              is given for 14 days under supervision. G6PD status of the patient must be
              determined before starting primaquine. Primaquine is contraindicated in preg-
              nant women.
              2.  Treatment of complicated malaria
                 All patients (including infants, pregnant women in all trimesters and lactating
              mothers) with severe malaria should be treated with intravenous or intramuscu-
              lar artesunate for at least 24  h or until they can tolerate oral medication.
              Artemether or quinine is given as an alternative if parenteral artesunate is not
              available.
                 ACT consists of an artemesinin derivative combined with a long-acting anti-
              malarial drug (amodiaquine, lumefantrine, mefloquine, or sulfadoxine-pyrimeth-
              amine). Artemesinin derivative must never be given as monotherapy to prevent
              development of parasite resistance to these drugs (Table 6.1).


              Prevention and Control

              1.  Chemoprophylaxis
                 For travellers visiting endemic areas, chemoprophylaxis provides effective
              protection. The drugs recommended are proguanil, chloroquine or mefloquine
              weekly or doxycycline daily. Prophylaxis should begin 1 week before travelling
              and be continued while in the endemic area and for 4–6 weeks after departure
              from endemic area.
              2.  Vector Control Strategies
               (a)  Insecticide residual spraying (IRS): The spraying of the indoor surfaces of
                  house with residual insecticides
                (b)  Insecticide treated bed nets (ITN)
                (c)  Use of repellants, protective clothing, mosquito coils and screening of
                  house
              3.  Anti-larval Measures
   50   51   52   53   54   55   56   57   58   59   60